Newsletter Tool

Weekly Digest

This Week

Dec 7, 2024

2024's Women of Influence

NYPD: 'Every indication' that shooting of UnitedHealthcare CEO was targeted, premeditated

How Republican 'red wave' in Washington could shake up healthcare, pharma policy: S&P

CMS names two drug manufacturers for cell and gene therapy model

Anthem faces backlash from new anesthesia policy, reverses course in all states - Paige Minemyer

Featured

2024's Women of Influence

By Heather Landi,Susan Kreimer

Meet our 2024 Women of Influence. Each of the 10 women profiled this year is playing a major role in driving the industry forward.

NYPD: 'Every indication' that shooting of UnitedHealthcare CEO was targeted, premeditated

By Paige Minemyer

As the hunt for the suspect continues, multiple news outlets are reporting that bullet casings found at the scene are proving to be central to the investigation as it moves into its second day.

How Republican 'red wave' in Washington could shake up healthcare, pharma policy: S&P

By Heather Landi

Analysts with S&P Global Ratings don't expect a major ratings impact for healthcare companies over the near to intermediate term, but anticipate changes will be a net negative for the industry from a credit perspective.

CMS names two drug manufacturers for cell and gene therapy model

By Noah Tong

The two drugs treat sickle cell disease, the stated first priority of the new CMS model set to begin in January.

Anthem faces backlash from new anesthesia policy, reverses course in all states

By Noah Tong

Anthem Blue Cross Blue Shield is rescinding its new policy on anesthesia after the company began receiving fresh scrutiny.

Bristol Myers Squibb latest drug company to sue HHS over 340B rebate model

By Heather Landi

Bristol Myers Squibb became the latest large drugmaker to sue the federal government over a plan to change how it doles out drug discounts to hospitals.

Signify Heath is expanding its offerings and making more visits. Here's how

By Paige Minemyer

CVS' home health arm Signify Health is set to make 3.3 million home visits this year, and the team isn't looking to stop there.

Primary care market will see major shifts by 2030 as payers, nontraditional providers gain ground

By Heather Landi

Nontraditional providers will account for about one-third of the primary care market in 2030, according to Bain & Company. Payer-owned primary care, population-focused models and advanced primary care providers are all poised for growth.

ICHRA-focused StretchDollar raises $6M with help from Oscar Health

By Noah Tong

Health benefits startup StretchDollar has raised $6 million, with help from Oscar Health, as the two companies put their weight behind ICHRAs.

Healthcare industry needs to get a grip on AI governance in 2025, ECRI warns

By Emma Beavins

A well-known safety group debuted its annual report that lays out the top 10 health technology risks for the upcoming year. The risks of AI perpetuating bias or hallucinating answers to medical questions tops the list of risks for 2025.

Fierce podcasts